Abattis Bioceuticals Inc. (OTCPK:ATTBF)
Abattis gives investors something to be bullish for. Of course I want to stress that investors should approach with caution. This stock exploded in the last month and I can tell investors have been scratching their heads trying to figure out why.
This company deserves its own write-up. As I've already covered this company before, I try not to be redundant. There are a lot of positives here.
Abattis is five companies in one. This is a "hedging strategy" in order to work in the current legal market. However, CEO of Abattis, Mike Withrow, has structured his company so that it can capitalize in a fully legalized market. Their main strategy, "GDERS," which stands for "Grow, Dry, Extract, Refine, Sell," is not only to diversify in this emerging market, but also maximize profits as an importer/exporter. The five subsidiaries of Abattis are:
•Biocube Green Grow has developed a modular unit, the "BioCube," that is 16x16x8, which can grow up to 240 plants in a single unit. The "Biocube" equipment is designed to modulate 240 plants individually to get the desired THC/CBD levels in the product. The 'BioCubes' are not only for growing cannabis but can be used with any type of plant life. Biocube is the 'Grow and Dry' portion of the 'GDERS' strategy. Additionally, Abattis' Biocube has recently acquired Green-Gro ltd. proprietary fertilizer formulae and juices. In exchange Green-Gro happily accepted 300,000 shares of Abattis. There are currently twenty-five stores throughout California, Oregon, Washington, and Colorado that carry Green-Gro products.
•Biocell Labs has a lease on a 13 million dollar facility, which will be used primarily for the 'refining' and 'selling.' Biocell has access to flash-freeze technology. In the world of cannabis refinement, flash-freeze will be able to extract CBDs without damaging the purity of the product. Biocell has applied for a license for the purgenesis facility.
•Northern Vine is set up for neutraceutic
Sentiment: Strong Buy
Nice post wiz, My Biocube long term projections.
This is what most investors are focused on, nice but ¼ of the business model.
Experion, (Abattis Partner) with license filed has 10 acres Ready for the BioCube when complete.
Squamish property (Abattis) has 6.5 acres.
16.5 acres total = 718740 sq-ft; Roads are required between the BioCube footprints so 60% of the total land area is usable. 431244 sq-ft remains x 1 BioCube footprint (16x8) 128 sq-ft / BioCude.
Abattis long term could potentially accommodate 3369ea BioCubes which grow 3200ea Plants each at 3 grow cycles per year. Total plant yield /year when built out; 32.3M plants per year. Each plant will yield 1 pound. 32,300,000 pounds x $2400 lb (Canada Rate) = $77.5B revenue / year.
Ok back to Earth! Look at it this way. Every BioCube will yield 9600 plants or Pounds per year. 9600Lbs x $2400/lb = 23M revenue / year / BioCube.
Updated Biocube info from From Mike..
The market price of the MMin Canada is currently $5.95 to $6.95 g
The Biocubes are 20' L X 16' W X 8ft H and can accommodate 820 plants each (1 gal pot and 60 to 80 cm plant)
Abattis Bioceuticals Corp.
#104 - 9295 198th Street
Langley, British Columbia
Canada V1M 3J9
this is easy money: buy the hell out of ATTBF, MNTR, FITX, and LATF. buy LATF just for kicks. #$%$ up 100,000 shares and then just forget about it for about a year. load up on Monday and by Tuesday these stocks should be rocking and rolling.
I agree about ERBB and EAPH. I need to scoop up them up also.
Sentiment: Strong Buy